14 August 2026
14 August 2026
In combination with ZDd, Zenbexus received the agency’s decision following results from the Phase III EXCALIBER-RRMM trial.
Khartis was co-founded two years ago by the team at XinThera, a biotech acquired by Gilead.
The project combines Xanadu’s algorithms team and the University of Alberta chemistry professor Alex Brown.
Recommended changes to the US immunisation schedule by President Trump have been met with widespread retaliation.
The authorisation is based on data from the HARMONi-6 multi-centre Phase III study that was conducted in China.
Repligen’s $1.5bn purchase of BioLife Solutions adds CryoStor biopreservation to its bioprocessing portfolio, underscoring pharma’s shift toward integrated cell and gene therapy supply chains.
Lilly is suing several US companies that are allegedly selling illegal versions of its weight loss candidate, retatrutide.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
